Drug Interactions between Doptelet and Promacta
This report displays the potential drug interactions for the following 2 drugs:
- Doptelet (avatrombopag)
- Promacta (eltrombopag)
Interactions between your drugs
No interactions were found between Doptelet and Promacta. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Doptelet
A total of 87 drugs are known to interact with Doptelet.
- Doptelet is in the drug class platelet-stimulating agents.
- Doptelet is used to treat the following conditions:
Promacta
A total of 186 drugs are known to interact with Promacta.
- Promacta is in the drug class platelet-stimulating agents.
- Promacta is used to treat the following conditions:
Drug and food interactions
eltrombopag food
Applies to: Promacta (eltrombopag)
Food may reduce the absorption and blood levels of eltrombopag. In addition, minerals such as aluminum, calcium, iron, magnesium, and zinc can also interfere with eltrombopag absorption into the bloodstream, which may make the medication less effective in treating your condition. You should take eltrombopag on an empty stomach one hour before or two hours after a meal. Eltrombopag should also be taken at least 2 hours before or 4 hours after products like antacids, mineral supplements, dairy products, and fortified juices. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
avatrombopag food
Applies to: Doptelet (avatrombopag)
Taking avatrombopag with food helps ensure consistent absorption of the medication into the blood stream. You should take each dose of avatrombopag with food at the same time everyday.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Platelet-stimulating agents
Therapeutic duplication
The recommended maximum number of medicines in the 'platelet-stimulating agents' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'platelet-stimulating agents' category:
- Doptelet (avatrombopag)
- Promacta (eltrombopag)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.